Company news
Lexeo Therapeutics, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
March 10, 2024
Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing
March 10, 2024
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments
February 4, 2024
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
December 17, 2023
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights
December 10, 2023
Calls
Decks
The 5 newest of 23 decks. Every deck is listed under its year.
- Investor Presentation (November 2026)
Investor deck · 37 slides · Nov 16, 2026
- Technical Presentation (November 2026)
Technical · 21 slides · Nov 16, 2026
- International Congress for Ataxia Research 2026
Conference · 14 slides · Nov 11, 2026
- Technical Presentation (November 2026)
Technical · 14 slides · Nov 7, 2026
- Technical Presentation (November 2026)
Technical · 14 slides · November 2026